Therefore, we examined the synaptic vesicle protein (VAMP2), syntaxin 1A, and SNAP-25 genetic variants that are related to synaptogenesis and neuroplasticity in patients with MS. The gene discussed is SNAP25; the disease is myeloid sarcoma.